Chemfab Alka. (CHEMFAB)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Debt/equity at 0.29 is manageable, so the balance sheet is not overly strained
• Promoter holding of 72.13% aligns insiders with minority shareholders
• Book value of ₹275.99 provides a tangible asset floor; the shares trade at 1.44x book
• A small dividend yield of 0.33% shows some cash return to shareholders despite losses

Concerns

• Latest quarter net loss of ₹4 Cr and P/E of 0.00 mean current earnings power is absent
• Sales growth of -18.51% and profit growth of -336.70% show severe business deterioration
• ROE of 2.48% and ROCE of 3.32% are far below acceptable returns on capital
• Piotroski F-Score of 3/9 and FairStock Score of 0/100 highlight high financial risk

AI Analysis

Let me examine Chemfab Alka the way I would any business. First, I look for earnings power. Here I find none: the latest quarter shows a net loss of ₹4 Cr on sales of ₹68 Cr, and annual profit growth has collapsed by 336.70%. With sales down 18.51%, the business is shrinking, not compounding. A P/E of 0.00 is not cheap; it is a warning that earnings have disappeared. Graham taught me that price is what you pay, value is what you get. At ₹398.45, I am being asked to pay 1.44 times book value of ₹275.99 for a company earning only 2.48% ROE and 3.32% ROCE. That return is below what a fixed deposit could give me, and it carries business risk on top. The Piotroski F-Score of 3 out of 9 further suggests weak financial health. I do see some positives: debt-to-equity of 0.29 is moderate, and promoter holding of 72.13% means insiders have skin in the game. But skin in the game is not the same as a durable moat. This is commodity chemicals; there is no pricing power unless you are the lowest-cost producer, and the falling sales and losses say Chemfab is not in that position today. The dividend yield of 0.33% is too small to compensate shareholders while they wait. The 52-week range of ₹290.35 to ₹764.00 shows how volatile this stock has been, but I am not interested in catching a falling knife. In my circle of competence, I want businesses with consistent profitability, clear competitive advantages, and management that creates value. Chemfab Alka currently fails these tests. It may be a cyclical company near the bottom, but I do not need to gamble on a turnaround. I would rather watch from the sidelines and wait for evidence of sustainable earnings before calculating any intrinsic value.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer